Dignify Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Dignify Therapeutics's estimated annual revenue is currently $2.3M per year.
- Dignify Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Dignify Therapeutics has 15 Employees.
- Dignify Therapeutics grew their employee count by 36% last year.
Dignify Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | VP, Chemistry | Reveal Email/Phone |
4 | VP Preclinical Research | Reveal Email/Phone |
5 | Director Operations | Reveal Email/Phone |
6 | Senior Research Scientist | Reveal Email/Phone |
Dignify Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.9M | 77 | 7% | N/A | N/A |
#2 | $6221.7M | 40140 | -4% | N/A | N/A |
#3 | $2M | 13 | 0% | N/A | N/A |
#4 | $0.8M | 5 | -55% | N/A | N/A |
#5 | $2.8M | 18 | 6% | $11.1M | N/A |
#6 | $1M | 13 | -41% | N/A | N/A |
#7 | $1.7M | 11 | 0% | N/A | N/A |
#8 | $0.6M | 4 | 0% | N/A | N/A |
#9 | $5.9M | 38 | -5% | N/A | N/A |
#10 | $6.8M | 44 | 7% | N/A | N/A |
What Is Dignify Therapeutics?
Developer of novel drug therapies intended to restore voluntary control of excretory function to neurologically impaired people. The company provides effective and convenient pharmaceutical agents that trigger the voiding of bladder and bowel contents when the person wishes, enabling patients with spinal cord injury, spina bifida, and other neurological conditions to have an enhanced way of life.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.8M | 18 | 6% | N/A |
#2 | $2.8M | 18 | 50% | N/A |
#3 | $2.8M | 18 | 13% | N/A |
#4 | $1.7M | 19 | 111% | N/A |
#5 | $1.6M | 20 | 33% | N/A |